IP Library Granted Patent US 9,624,473
Granted Patent B2
US 9,624,473 · App. 13/775,536 · Granted Apr 18, 2017

Three-dimensional fibrous scaffolds for cell culture

Inventors: Subhra Mohapatra (Tampa, FL); Shyam S. Mohapatra (Tampa, FL); Yvonne Kathleen Davis (Tampa, FL); Chunyan Wang (Tampa, FL)
C12N5/0693C12N5/0062C12N5/0068C12N2533/40C12N2533/72
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,624,473
App. No.
13/775,536
Granted
Apr 18, 2017
Kind
B2
Abstract

Provided herein is a three-dimensional scaffold composition comprising randomly oriented fibers, wherein the fibers comprise a polyethylene glycol-polylactic acid block copolymer (PEG-PLA) and a poly(lactic-co-glycolic acid) (PLGA). Also provided are methods for using the three-dimensional scaffolds described herein.

Claims (6)

1. A three-dimensional scaffold composition consisting of a three-dimensional scaffold of randomly oriented nanofibers, wherein the fibers consist of polyethylene glycol-polylactic acid block copolymer (PEG-PLA) and poly(lactic-co-glycolic acid) (PLGA), wherein ratio of PEG-PLA to PLGA is approximately 1:4 with fiber diameter ranges from approximately 0.69 to 4.18 micrometers and with pores having a diameter of less than approximately 10 micrometers, and a spheroid comprising a homogenous population of cancer cells generated from an isolated cancer cell from a tumor or a cultured cancer cell line.

2. The composition of claim 1 , wherein the PEG has a molecular weight of approximately 2 kDa.

3. The composition of claim 1 , wherein the PLGA has a lactic acid: glycolic acid ratio of approximately 85:15.

4. The composition of claim 1 , wherein the PEG has a molecular weight of approximately 2 kDa, and wherein the PLGA has a lactic acid:glycolic acid ratio of approximately 85:15.

5. The composition of claim 1 , wherein the three-dimensional scaffold has a chitosan coating.

6. The composition of claim 1 , wherein the cultured cancer cell line is selected from the group consisting of: MCF-7 cells, MDA-MB cells, MCF-10A breast cancer cells, PC3 prostate cancer cells, B16 melanoma cells, BG-1 ovarian cells, and LLC Lewis lung cancer cells.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 23, 2018
From: SOUTH FLORIDA, UNIVERSITY OF
To: NAVY, SECRETARY OF THE UNITED STATES OF AMERICA
Reel/Frame 046622/0577 →
CONFIRMATORY LICENSE Recorded Mar 14, 2018
From: SOUTH FLORIDA, UNIVERSITY OF
To: NAVY, SECRETARY OF THE UNITED STATES OF AMERICA
Reel/Frame 045604/0843 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 14, 2013
From: MOHAPATRA, SUBHRA; MOHAPATRA, SHYAM S.; DAVIS, YVONNE KATHLEEN; WANG, CHUNYAN
To: UNIVERSITY OF SOUTH FLORIDA (A FLORIDA NON-PROFIT CORPORATION)
Reel/Frame 030410/0462 →
Continuity (3)
Provisional Application 61602337 · Feb 23, 2012
Provisional Application 61723922 · Nov 8, 2012
Related Publication 20130224860A1 · Aug 29, 2013